• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad, June 25

Dr Reddy's Laboratories Ltd has announced the launch of authorised generic version of Merck & Company's cholesterol drug Zocor (simvastatin) in 5mg, 10mg, 20mg, 40mg and 80mg doses on Friday following the expiry of compound patents for the drug.

In a press release here, the company said it had entered into separate agreements with Merck that allowed it to launch the authorised generic versions of Proscar (cancer drug) and Zocor.

However, the company did not disclose the specific financial terms and conditions of the agreement. The company had launched the generic version of Proscar in 5 mg tablets form on June 19 following the expiry of the compound patent. The innovator sales for this drug stood at $393-million, while that of Zocor amounted to $4.5-billion.

More Stories on : Announcements | New Products & Services | Pharmaceuticals | Dr. Reddy's Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Dr Reddy's launches generic Zocor

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line